These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23257936)

  • 41. Mild traumatic brain injury: evaluation of olfactory dysfunction and clinical-neurological characteristics.
    Ciofalo A; De Vincentiis M; Iannella G; Zambetti G; Giacomello P; Altissimi G; Greco A; Fusconi M; Pasquariello B; Magliulo G
    Brain Inj; 2018; 32(5):550-556. PubMed ID: 29446651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Smell as a clinical-marker for functional limitations in multiple sclerosis: A pilot study.
    Goverover Y; Chen MH; Costa SL; Chiaravalloti ND; DeLuca J
    Mult Scler Relat Disord; 2020 Nov; 46():102508. PubMed ID: 33011622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Olfactory bulb volume and olfactory function in patients with multiple sclerosis.
    Goektas O; Schmidt F; Bohner G; Erb K; Ludemann L; Dahlslett B; Harms L; Fleiner F
    Rhinology; 2011 Jun; 49(2):221-6. PubMed ID: 21743881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does imaging of the olfactory tract change the clinical management of patients with olfactory disturbance? A case series of 100 consecutive patients.
    Powell J; Elbadawey MR; Zammit-Maempel I
    J Laryngol Otol; 2014 Sep; 128(9):810-3. PubMed ID: 25160597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of cognition, quality of life, and fatigue on olfactory function in patients with multiple sclerosis.
    Acikgoz M; Piri Cinar B; Aciman Demirel E; Celebi U; Cekic S; Elicora S; Atasoy HT
    Clin Neurol Neurosurg; 2023 Jun; 229():107739. PubMed ID: 37146370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Olfactory dysfunction in Multiple Sclerosis: A scoping review of the literature.
    Lucassen EB; Turel A; Knehans A; Huang X; Eslinger P
    Mult Scler Relat Disord; 2016 Mar; 6():1-9. PubMed ID: 27063616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Olfactory loss in multiple sclerosis.
    Zivadinov R; Zorzon M; Monti Bragadin L; Pagliaro G; Cazzato G
    J Neurol Sci; 1999 Oct; 168(2):127-30. PubMed ID: 10526195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smell functions in patients with multiple sclerosis: a prospective case-control study.
    Kandemir S; Muluk NB; Melikoglu B; Dag E; Inal M; Sarin O
    B-ENT; 2016; 12(4):323-331. PubMed ID: 29709137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Olfaction in multiple sclerosis. With a note on the discrepancy between optic and olfactory involvement.
    Ansari KA
    Eur Neurol; 1976; 14(2):138-45. PubMed ID: 174916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis.
    Caminiti F; De Salvo S; De Cola MC; Russo M; Bramanti P; Marino S; Ciurleo R
    PLoS One; 2014; 9(7):e103151. PubMed ID: 25047369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Olfactory alterations in patients with multiple sclerosis.
    Jordy SS; Starzewski A; Macedo FA; Manica GR; Tilbery CP; Carabetta EG
    Arq Neuropsiquiatr; 2016 Sep; 74(9):697-700. PubMed ID: 27706416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical testing of olfaction reassessed.
    Pinching AJ
    Brain; 1977 Jun; 100(2):377-88. PubMed ID: 884490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Olfactory disturbances as the initial or most prominent symptom of multiple sclerosis.
    Constantinescu CS; Raps EC; Cohen JA; West SE; Doty RL
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):1011-2. PubMed ID: 8057099
    [No Abstract]   [Full Text] [Related]  

  • 54. The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis.
    Almasi M; Sahraian MA; Haji Akhoundi F; Ezzati HR; Rohani M
    Basic Clin Neurosci; 2021; 12(1):89-94. PubMed ID: 33995931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Olfaction in the context of obesity and diabetes: Insights from animal models to humans.
    Faour M; Magnan C; Gurden H; Martin C
    Neuropharmacology; 2022 Mar; 206():108923. PubMed ID: 34919903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Olfactory dysfunction as a marker of multiple sclerosis progression.
    Pimentel ML
    Arq Neuropsiquiatr; 2016 Sep; 74(9):693-694. PubMed ID: 27706414
    [No Abstract]   [Full Text] [Related]  

  • 57. Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.
    Mirmosayyeb O; Ebrahimi N; Barzegar M; Afshari-Safavi A; Bagherieh S; Shaygannejad V
    PLoS One; 2022; 17(4):e0266492. PubMed ID: 35439251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative Study of Brain fMRI of Olfactory Stimulation in Neuromyelitis Optica Spectrum Disease and Multiple Sclerosis.
    He S; Peng T; He W; Gou C; Hou C; Tan J; Wang X
    Front Neurosci; 2021; 15():813157. PubMed ID: 35082598
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review.
    Krajnc N; Bsteh G; Berger T
    Front Neurol; 2021; 12():666868. PubMed ID: 34512500
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.